STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

AstraZeneca PLC furnished a Form 6-K announcing an update to its corporate governance documents. Exhibit 99.1 contains the company’s Articles of Association, adopted by special resolution passed on 3 November 2025. The filing indicates AstraZeneca files annual reports on Form 20-F and is not furnishing information under Rule 12g3-2(b).

Positive
  • None.
Negative
  • None.

 

 

 

FORM 6-K

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

Report of Foreign Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

 

For the month of November 2025

 

Commission File Number: 001-11960

 

AstraZeneca PLC

 

1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA
United Kingdom

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x
Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨ No x

 

If “Yes” is marked, indicate below the file number assigned to the Registrant in connection with Rule 12g3-2(b): 82- __________

 

 

  

 

 

 

Exhibit List

 

Exhibit No. Description
   
99.1 Articles of Association adopted by special resolution passed on 3 November 2025

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ASTRAZENECA PLC
     
Date: November 3, 2025 By: /s/ Matthew Bowden
    Name: Matthew Bowden
    Title: Company Secretary

 

 

 

FAQ

What did AZN file with the SEC?

AstraZeneca PLC furnished a Form 6-K.

What is included as Exhibit 99.1 in AZN’s 6-K?

The Articles of Association adopted by special resolution on 3 November 2025.

When were the new Articles of Association adopted by AZN?

They were adopted on 3 November 2025 by special resolution.

Does AZN file annual reports on Form 20-F or 40-F?

AZN files annual reports on Form 20-F.

Is the information furnished under Rule 12g3-2(b)?

No; the filing marks No for Rule 12g3-2(b) furnishing.

Who signed the 6-K for AstraZeneca?

It was signed by Matthew Bowden, Company Secretary, on November 3, 2025.
Astrazeneca Plc

NASDAQ:AZN

AZN Rankings

AZN Latest News

AZN Latest SEC Filings

AZN Stock Data

255.48B
3.10B
0%
16.74%
0.25%
Drug Manufacturers - General
Healthcare
Link
United Kingdom
Cambridge